Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 746)
Posted On: 08/07/2020 6:57:34 AM
Post# of 154011
Posted By: ohm20
Re: SAF #47678
Dovato use could lead to resistance and could exclude switching over to some current HAART treatments. Leronlimab is the only HIV drug that doesn't develop resistance, patients would have to turn to us.


Quote:
Strong warning against Dovato 2-drug regimen as first-line therapy by San Francisco HIV expert



https://www.sfaf.org/collections/beta/strong-...iv-expert/













(3)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site